Literature DB >> 9859037

[Optimal management of primary and secondary mitral regurgitation].

C Piper1, M Wiemer, H P Schultheiss, D Horstkotte.   

Abstract

While morphologic alteration of parts of the mitral valve apparatus (ventricular wall, papillary muscles, chordae tendineae, valve annulus and leaflets) may result in a loss of its functional integrity (primary mitral regurgitation, MR) mitral annulus dilatation following left ventricular enlargement or change in chamber geometry and consecutive opening of the angle between papillary muscles and valve annulus cause secondary MR. Irrespective of these etiologies MR is chronically progressive and much more than the severity of MR the grade of myocardial adaptation to the chronic volume overload is of prognostic significance. Inadequate myocardial adaptation is demonstrated by an increase of the echocardiographically determined radius (r) to wall thickness (Th) ratio (r/Th > 3.0), indicating increasing left ventricular wall stress or by an insufficient increase of the left ventricular ejection fraction (< or = 5% of resting values) under exercise conditions, e.g. with radionuclide angiocardiography (RNV). Stressecho may replace RNV in the future for this indication. Actually, stress echo is not reliable to determine changes in left ventricular ejection fraction at rest versus exercise because of systematic errors and error reproduction. There are preliminary reports on biochemical markers like noradrenaline or tumor necrosis factor alpha being helpful to determine the breakdown of myocardial adaptation mechanisms. Surgical intervention is indicated in chronic MR irrespective of the hemodynamic severity, if myocardial adaptation is inadequate. If mitral reconstruction, the surgical technique of choice, remains insufficient to restore normal valve function, mitral valve replacement with preservation of the subvalvular apparatus is unavoidable. For a deceleration of the progressive volume overload in chronic MR for which a surgical intervention is not yet indicated, a long-term afterload reducing medical therapy preferably with long acting ACE-inhibitors seem to be prognostically favorable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9859037     DOI: 10.1007/bf03043403

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  12 in total

1.  How leaky is that mitral valve? Simplified Doppler methods to measure regurgitant orifice area.

Authors:  J D Thomas
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

2.  Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta.

Authors:  S A Hall; M E Brickner; D L Willett; W N Irani; I Afridi; P A Grayburn
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

Review 3.  Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.

Authors:  H J Levine; W H Gaasch
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

4.  Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography.

Authors:  D Y Leung; B P Griffin; W J Stewart; D M Cosgrove; J D Thomas; T H Marwick
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

5.  Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up.

Authors:  B H Greenberg; H DeMots; E Murphy; S H Rahimtoola
Journal:  Circulation       Date:  1982-01       Impact factor: 29.690

6.  Value of systolic pulmonary venous flow reversal and color Doppler jet measurements assessed with transesophageal echocardiography in recognizing severe pure mitral regurgitation.

Authors:  E P Pieper; I M Hellemans; H P Hamer; A C Ravelli; E C Cheriex; J G Tijssen; K I Lie; C A Visser
Journal:  Am J Cardiol       Date:  1996-08-15       Impact factor: 2.778

7.  Usefulness of color Doppler proximal isovelocity surface area method in quantitating valvular regurgitation.

Authors:  S Yamachika; C L Reid; D Savani; C Meckel; J Paynter; M Knoll; B Jamison; J M Gardin
Journal:  J Am Soc Echocardiogr       Date:  1997-03       Impact factor: 5.251

Review 8.  Indications for surgery in mitral regurgitation.

Authors:  J Acar; P L Michel; P Luxereau; A Vahanian; B Cormier
Journal:  Eur Heart J       Date:  1991-07       Impact factor: 29.983

9.  Quinapril therapy in patients with chronic mitral regurgitation.

Authors:  H R Schön; G Schröter; P Barthel; A Schömig
Journal:  J Heart Valve Dis       Date:  1994-05

10.  Effects of a single oral dose of captopril on left ventricular performance in severe mitral regurgitation.

Authors:  T Wisenbaugh; R Essop; C Rothlisberger; P Sareli
Journal:  Am J Cardiol       Date:  1992-02-01       Impact factor: 2.778

View more
  2 in total

1.  Bicuspid aortic valve.

Authors:  D Horstkotte
Journal:  Z Kardiol       Date:  2005-07

Review 2.  [Modern aspects in the management of acquired heart valve lesions].

Authors:  D Horstkotte; H P Schultheiss
Journal:  Herz       Date:  1998-11       Impact factor: 1.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.